Engineering receptors activated solely by synthetic ligands (RASSLs)
- 1 August 2001
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (8) , 414-420
- https://doi.org/10.1016/s0165-6147(00)01743-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Unnatural Ligands for Engineered Proteins: New Tools for Chemical GeneticsAnnual Review of Biophysics, 2000
- Conditional expression of a G i -coupled receptor causes ventricular conduction delay and a lethal cardiomyopathyProceedings of the National Academy of Sciences, 2000
- Conversion of agonist site to metal-ion chelator site in the β 2 -adrenergic receptorProceedings of the National Academy of Sciences, 1999
- Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic miceNature Biotechnology, 1999
- Controlling signaling with a specifically designed G i -coupled receptorProceedings of the National Academy of Sciences, 1998
- Functional analysis of Fas signaling in vivo using synthetic inducers of dimerizationCurrent Biology, 1996
- Diuretic Effects, Pharmacokinetics, and Safety of a New Centrally Acting Kappa‐Opioid Agonist (CI‐977) in HumansThe Journal of Clinical Pharmacology, 1994
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- The cardiovascular and central nervous system effects in the human of U-62066EEuropean Journal of Clinical Pharmacology, 1994
- Receptor-Effector Coupling by G Proteins: Implications for Normal and Abnormal Signal TransductionEndocrine Reviews, 1992